Nanograb
Nanograb develops generative AI approaches to design nanoparticles for cell-selective drug delivery, aiming to enable drugs to treat diseases without side effects.
About Nanograb
Nanograb is a computational drug discovery company that uses AI to create novel targeted non-viral gene therapy vectors. Our platform designs unique combinations of small peptide binders attached to nanoparticles to safely deliver genetic medicines to specific cells and tissues in the body at scale.
Products
A platform using generative AI and multivalent nanoparticles with next-generation targeting capabilities to deliver genes to any cell.
Security and compliance
No security details published yet
Nanograb hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Nanograb